Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 737.3B | 743.3B | 701.4B | 651.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 268.1B | -33.9B | 121.5B | 109.2B |
Other operating expenses | 17.5B | 188.9B | 22.8B | 27.6B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 244.4B | 313.5B | 375.2B | 331.7B |
Tax provision | 55.9B | 63.9B | 67.5B | 68.9B |
Net income | 188.6B | 249.7B | 318.5B | 267.9B |
Basic EPS | 721 | — | — | — |
Diluted EPS | 721 | — | — | — |
Basic average shares | 259.1M | — | — | — |
Diluted average shares | 259.1M | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | 186.8B | 248.5B | 317.4B | 266.9B |
Minority interests | -1.8B | -1.3B | -1.1B | -1.0B |
Preferred stock dividends | — | — | — | — |